Posted by sobikobtijan on March 14th, 2017

2These particularly are excellent at characterizing the endocannabinoid deficiency-type of syndrome. 22What it comes down is these diseases may be the first of the endocannabinoid system dysfunction 2deficiency that can be corrected and can be targeted with the endocannabinoid enhancement 2therapy that we’re all using. 2In other areas like the brain, you mentioned the Alzheimer’s disease. 2There’s also Parkinson’s. 2There are others. 2ALS has been shown. 2All of these conditions are now showing endocannabinoid dysfunction. 2That means that either the endocannabinoid hormones are too high, or they’re too low, 22or the receptors are wonky. 22They’re just not around in the right concentration. 22That

Link To Directory
Top Searches - Trending Searches - New Articles - Top Articles - Trending Articles - Featured Articles - Top Members

Copyright 2020
706,092 total articles and counting.